Richard J. Berman

CIK: 0001111620

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

BIVI

BIOVIE INC.

Director

CELU

Celularity Inc

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

BIVI
BIOVIE INC.
Dec 20, 2024
Award(A)
Stock Option (right to buy)
Direct
23.2K shares-
CELU
Celularity Inc
Dec 19, 2024
Award(A)
Direct
67.4K shares-
BIVI
BIOVIE INC.
Nov 20, 2024
Award(A)
Direct
34.2K shares-

		Type	Shares	Price		Ownership
Dec 20, 2024	BIVI BIOVIE INC.	Award(A) Stock Option (right to buy)	23,155	-	-	Direct
Dec 19, 2024	CELU Celularity Inc	Award(A)	67,416	-	$0	Direct
Nov 20, 2024	BIVI BIOVIE INC.	Award(A)	34,200	-	$0	Direct

1-3 of 3 transactions

About BERMAN RICHARD J

BERMAN RICHARD J (SEC CIK 0001111620) files insider reports with the SEC as Director of BIOVIE INC. (BIVI) and Director of Celularity Inc (CELU).

Signal8 holds 2 ownership filings by BERMAN RICHARD J, all Form 4s, filed between Jan 6, 2025 and Jan 7, 2025. Those filings report 3 transactions, from Nov 20, 2024 to Dec 20, 2024. Signal8's Form 4 history starts in Sep 2024.

The business address on BERMAN RICHARD J's filings is in FLORHAM PARK, NJ.

Recent filings by BERMAN RICHARD J

Dec 20, 2024: Grant or award of BIVI derivative securities (Form 4, code A).
Dec 19, 2024: Grant or award of CELU shares (Form 4, code A).
Nov 20, 2024: Grant or award of BIVI shares (Form 4, code A).

Other insiders filing for BIOVIE INC. (BIVI)

Palumbo Joseph M, Chief Medical Officer
Chappell Amy Suzon, Director
KIM JOANNE WENDY, Chief Financial Officer
DO CUONG V, President & CEO
ROGICH SIGMUND, Director
Sherman Michael Edward, Director

How to read Form 4 transaction codes